InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Winningham Rick E, Chairman & CEO. Insider active across 2 companies, notably Theravance Biopharma, Inc.. In total, 41 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €1m. History available since 20 May 2021. The latest transaction was filed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Winningham Rick E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
20,034 shares@ US$16.950.038% mcap6.1% of flowOrdinary SharesSEC:0001302443-26-000012:0
1,605 shares0Ordinary SharesSEC:0001302443-26-000010:0
75,000 shares0Ordinary SharesSEC:0001302443-26-000004:0
74,975 shares@ US$19.6627.8% of flowOrdinary SharesSEC:0001302443-26-000002:0
9,900 shares0Ordinary SharesSEC:0001302443-25-000008:0
5,500 shares@ US$180.859784.0% of flowOrdinary SharesSEC:0001302443-25-000006:0
15,394 shares@ US$13.395.4% of flowOrdinary SharesSEC:0001415889-25-022803:0
3,507 shares0Ordinary SharesSEC:0001765581-25-000078:0
20,000 shares0Ordinary SharesSEC:0001415889-25-018221:0
9,600 shares0Ordinary SharesSEC:0001415889-25-017585:0
15,364 shares@ US$9.453.7% of flowOrdinary SharesSEC:0001415889-25-014263:0
2,178 shares@ US$9.350.6% of flowOrdinary SharesSEC:0001415889-25-006684:0
35,129 shares@ US$9.669.4% of flowOrdinary SharesSEC:0001415889-25-005357:0
15,997 shares@ US$9.974.3% of flowOrdinary SharesSEC:0001415889-24-027573:0
3,193 shares@ US$9.570.8% of flowOrdinary SharesSEC:0001415889-24-027297:0
15,997 shares@ US$8.223.4% of flowOrdinary SharesSEC:0001415889-24-022092:0
3,252 shares@ US$7.830.7% of flowOrdinary SharesSEC:0001415889-24-021057:0
3,731 shares0Ordinary SharesSEC:0001765581-24-000079:0
15,997 shares@ US$9.103.9% of flowOrdinary SharesSEC:0001415889-24-014141:0
2,068 shares@ US$9.850.5% of flowOrdinary SharesSEC:0001415889-24-013612:0
300,000 shares0Ordinary SharesSEC:0001415889-24-010328:0
2,704 shares@ US$8.640.6% of flowOrdinary SharesSEC:0001415889-24-008630:0
37,196 shares@ US$8.928.9% of flowOrdinary SharesSEC:0001415889-24-004968:0
15,804 shares@ US$10.374.3% of flowOrdinary SharesSEC:0001415889-23-015454:0
15,804 shares@ US$9.704.1% of flowOrdinary SharesSEC:0001415889-23-012522:0
25 of 41 declarations
About Winningham Rick E
Winningham Rick E is Président-Directeur Général and has filed 39 disclosures in total. Across the 39 sampled filings, the activity spans from 2021-05-24 to 2026-04-03, with 0 in purchases and 1021487 in sales, and the most common transaction nature being tax withholding. He is linked to Theravance Biopharma, Inc., where his role is CHIEF EXECUTIVE OFFICER, and to Jazz Pharmaceuticals plc, where his role is Director.
